These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21455061)

  • 21. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical impact of combination antiretroviral therapy].
    Gatanaga H
    Nihon Rinsho; 2002 Apr; 60(4):739-44. PubMed ID: 11968781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergencies in HIV--part 2.
    Rewari BB; Purohit V; Chhabra RM; Bhagwan J
    J Assoc Physicians India; 2008 Oct; 56():783-6. PubMed ID: 19263705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the influence of therapy and viral suppression on high-risk sexual behaviour and sexually transmitted infections among patients infected with human immunodeficiency virus in Taiwan.
    Chen SC; Wang ST; Chen KT; Yan TR; Tang LH; Lin CC; Yen SF
    Clin Microbiol Infect; 2006 Jul; 12(7):660-5. PubMed ID: 16774563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and risk of pulmonary disease.
    Rosen MJ
    Semin Respir Infect; 1999 Dec; 14(4):301-8. PubMed ID: 10638509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammation and HIV].
    Bricaire F; Valantin MA
    Bull Acad Natl Med; 2011 Mar; 195(3):531-42; discussion 543-4. PubMed ID: 22292303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations of infection with human immunodeficiency virus among adolescents in Louisiana.
    Fuller C; Clark RA; Kissinger P; Abdalian SE
    J Adolesc Health; 1996 Jun; 18(6):422-8. PubMed ID: 8803734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late presentation of HIV-infected individuals.
    Battegay M; Fluckiger U; Hirschel B; Furrer H
    Antivir Ther; 2007; 12(6):841-51. PubMed ID: 17926639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis and HIV co-infections in Jamaican children.
    Geoghagen M; Farr JA; Hambleton I; Pierre R; Christie CD
    West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.